Per cent of patients with a ≥5-point improvement from baseline in the total HIT-6 score | OnabotulinumtoxinA (n=688) | ||
---|---|---|---|
Treatment cycle 1 | Treatment cycle 2 | Treatment cycle 3 | |
387 (56.3) | 100 (14.5) | 53 (7.7) |
*First-time responders for a given time point are patients who never responded at any previous time points.
HIT, Headache Impact Test.